The immunomodulatory hormone 1.25-dihydroxyvitamin D3 (1,25-(OH)2D3) has been shown t o suppress T-cell proliferation and interleukin-2 synthesis as well as 6-cell immunoglobulin synthesis, while stimulating many macrophage functions. We have previously shown increased synthesis of interleukin-1f3 in lipopolysaccharide (LPS)-stimulated U937 cells after pretreatment with 10 nmol/L 1,25-(0H)2D~. We now show that 1,25-(OH)zD3 also primes the increase in U937 cell tumor necrosis factor (TNF)-a-accumulated mRNA after activation with LPS; 50% effective concentration (ECso) for the LPS-induced expression of TNF-a mRNA was decreased by two orders of magnitude after incubation with 10 nmol/L 1,25-(OH)2D3. Pretreatment of U937 cells with 10 nmol/L 1,25-(OH)2D3 also increased subsequent LPS-induced TNF-a mRNA expression by twofold and cell-associated TNF protein levels by more than ninefold. This potentiation was steroid-specific for 1,25-(Oti)2D3 because dexamethasone HERE IS mounting evidence that 1,25-dihydroxyvita-T min D3 (1, is known to be a stimulator of monocyte/macrophage function.6 These stimulatory effects include an increase in expression of important monokine genes, including interleukin-10 (IL-lp). ' We recently showed that cells from the human myelomonocytic cell line U937 were well suited to a study of 1,25-(OH)2D3 regulation of lipopolysaccharide (LPS)-stimulated IL-10 gene expression and protein production.8 Moreover, we showed that exposure of U937 cells to a VDR-saturating concentration of the hormone markedly increased IL-10 gene expression in response to LPS. In this report we show that this remarkable 1,25-(0H)zD3-mediated enhancement of LPSresponsiveness can be extended to another important monokine, tumor necrosis factor-a (TNF-a), and is likely to result from hormone-mediated induction of the highaffinity receptor molecule for LPS, CD14, on U937 cells.
The immunomodulatory hormone 1.25-dihydroxyvitamin D3 (1,25-(OH)2D3) has been shown t o suppress T-cell proliferation and interleukin-2 synthesis as well as 6-cell immunoglobulin synthesis, while stimulating many macrophage functions. We have previously shown increased synthesis of interleukin-1f3 in lipopolysaccharide (LPS)-stimulated U937 cells after pretreatment with 10 nmol/L 1,25-(0H)2D~. We now show that 1,25-(OH)zD3 also primes the increase in U937 cell tumor necrosis factor (TNF)-a-accumulated mRNA after activation with LPS; 50% effective concentration (ECso) for the LPS-induced expression of TNF-a mRNA was decreased by two orders of magnitude after incubation with 10 nmol/L 1,25-(OH)2D3. Pretreatment of U937 cells with 10 nmol/L 1,25-(OH)2D3 also increased subsequent LPS-induced TNF-a mRNA expression by twofold and cell-associated TNF protein levels by more than ninefold. This potentiation was steroid-specific for 1,25-(Oti)2D3 because dexamethasone HERE IS mounting evidence that 1,25-dihydroxyvita-T min D3 (1, 25 -(OH)zD3), the hormonal form of vitamin D, may play a key role in modulating the human immune response at local sites of inflammation. Antigen-or mitogenactivated lymphocytes but not quiescent lymphocytes express receptors for 1,25-(OH)2D3 (VDR).' Tissue macrophages and circulating monocytes also express the VDR2 and are capable of constitutive or stimulated production of 1,25-(OH)2D3 from 25-OH D3,334 an enzymatic reaction otherwise relegated almost exclusively to the proximal renal tubular epithelial celL5 Whereas the bioresponsiveness of activated lymphocytes is generally inhibited by 1,25-(OH)2D3, the hormone is known to be a stimulator of monocyte/macrophage function.6 These stimulatory effects include an increase in expression of important monokine genes, including interleukin-10 (IL-lp). ' We recently showed that cells from the human myelomonocytic cell line U937 were well suited to a study of 1,25-(OH)2D3 regulation of lipopolysaccharide (LPS)-stimulated IL-10 gene expression and protein production.8 Moreover, we showed that exposure of U937 cells to a VDR-saturating concentration of the hormone markedly increased IL-10 gene expression in response to LPS. In this report we show that this remarkable 1,25-(0H)zD3-mediated enhancement of LPSresponsiveness can be extended to another important monokine, tumor necrosis factor-a (TNF-a), and is likely to result from hormone-mediated induction of the highaffinity receptor molecule for LPS, CD14, on U937 cells.
MATERIALS AND METHODS
Cell culture and stimulation. U937 cells (CRL 1593) were obtained from American Type Culture Collection (ATCC) (Rockville, MD) and maintained in culture media RPMI 1640 (GIBCO, Grand Island, NY) containing 10% heat-inactivated fetal bovine serum (GIBCO), nonessential amino acids (0.1 mmol/L), sodium pyruvate (0.1 mmol/L), 100 UimL penicillin, 100 mg/mL streptomycin, and 4 mmol/L glutamine. Cells were grown in an incubator at 37°C in 95% air:5% CO2 and diluted 15 from approximately 1 x 106 cells/mL every 2 to 3 days. 1,25-(OH)2D3 was purchased from Biomol Research Laboratories (Plymouth Meeting, PA), solubiinhibited TNF-a mRNA. The potentiation required prior exposure t o 1,25-(OH)& for more than 6 hours and was clearly seen after 12 hours. The finding that the sensitivity of the U937 cell monokine response t o LPS was dramatically increased by 1,25-(Oti)2D3 and the delayed effect on the LPS-stimulated TNF-a gene transcript levels indicated that 1,25-(OH)2D3 may be altering the expression of a protein(s) in the U937 cell LPS-signal transduction pathway. In fact, 1,25-(OH)&3 induced expression of the mRNA for CD14, the high affinity, cell-surface glycoprotein receptor for LPS, which could account for the enhancement of LPS-stimulated monokine gene expression by 1,25-(OH)& Thus, local monokine gene expression may be regulated by both the amount and the temporal entry of the vitamin D hormone and activatorb) into the inflammatory microenvironment.
o 1992 by The American Society of Hematology.
lized in ethanol, and added to cultures so that ethanol was no more than 0.1% final volume. LPS was from Sigma (St Louis, MO).
After activation, flasks were placed on a bed of ice and agitated to cool quickly. Suspended cells (1 X lo6 cells/mL in a total volume of 20 to 40 mL) were pelleted at 4°C and the pellet rapidly dissolved by vortexing into a solution of guanidinium thiocyanate (as in reference no. 9 except guanidinium thiocyanate was 5 mol/L and 2-mercaptoethanol was 5%) and stored at -80°C. For RNA extraction, samples were quickly thawed and passed 10 times through a 22-gauge hypodermic needle to shear high molecular weight DNA. RNA was extracted from the solution with phenol/chloroform following the procedure of Chomczynski and S a~c h i .~ Sample purity was assessed by standard analysis of absorbance scans (200 to 300 nm) on a Beckman DM-70 spectrophotometer (Beckman Instruments, Imine, CA) and total RNA was quantitated using absorbance at 260 nm.
RNA was aliquoted on the basis of absorbance at 260 nm, heated at 60°C for 3 to 4 minutes in standard formaldehyde-50% formamide sample buffer, and placed on ice. Total RNA was subjected to electrophoresis in a 1.2% agarose-formaldehyde gel in MOPS buffer (0.2 mol/L morpholinopropanesulfonic acid, 50 mmol/L EDTA, pH 7.0) for 14 hours at 1.25 V/cm. The gel was stained in dilute ethidium bromide for 10 minutes, destained in water for 30 minutes with gentle rocking, and photographed on a 302 nm UV transilluminator (using a Kodak 23A orange filter; Eastman Kodak, Inc, Rochester, NY) with Polaroid type 57 film. From this photograph, integrity of the 
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ribosomal bands as well as uniformityof amount of RNA present in each lane was assessed. The gel was blotted to Nytran (Schleicher and Schuell, Keene, NH) with transfer buffer ( l o x SSC: 1.5 mol/L NaCI, 0.15 mol/L sodium citrate, pH 7.0) for 24 hours and RNA was crosslinked to the membrane by UV light. Blots were probed according to Church and Gilbert1" using a 1.1-kb EcoRI human TNF-a cDNA segment," a 2.1-kb BamHl human y-actin cDNA segment," or a 400-bp Sst I-Xho I CD14 cDNA segment, kindly provided by Dr Sanna M. Goyert." The cDNA segments were labeled to high specific activity ( > 1OYcpm/pg) with a-"P deoxycytidine triphosphate by random hexanucleotide pri~ning.'~.'~ After removing unincorporated label and boiling, the labeled probe (approximate activity -3 x IO7 cpm/mL) was incubated with blots for 18 hours at 65°C with continuous tilting to ensure thorough mixing. Blots were washedlh and exposed at -80°C to Kodak X A R J film (Eastman Kodak, Inc) using a Cronex Lightning Plus intensifying screen (E.I. du Pont de Nemours and Co, Boston, MA). Transcript levels were quantified by scanning exposures in the linear exposure range for X A R J on an EDC integrating densitometer (Helena Labs, Beaumont, TX). Approximate molecular weight of transcripts was determined by comparison to the 18s and 28s ribosomal bands. 
RESULTS
Thc cffcct of 1,25-(OH)zD3 on LPS-stimulated TNF-a cytokine synthesis was examined in U937 cells. Figure 1A shows mRNA levels for TNF-a in U937 cells activated with 25 yg/mL LPS for 2.5 hours in the absence and presence of a VDR-saturating concentration of 1,25-(OH)zD3 for 24 hours beforc LPS activation or dcxamethasone administered concurrently with LPS. Compared with the glucocorticoid analogue dexamethasone, which decreased TNF-a mRNA levels, incubation of U937 cells with 1,25-(OH)2D3 resulted in a twofold or greater increase in steady-state TNF-a mRNA levels (Fig IA) . Furthermore, cocxposure of cells to both steroids rcsulted in intermediate transcript levels, lower than those observed in 1,25-(OH)2D3-pretreated cclls activated with LPS (third lane, Fig 1A) but higher than those observed in activated cells exposed solcly to the glucocorticoid (second lane, Fig lA) , showing competitive antagonism between actions of the two stcroids. In addition to potentiating the response, 1,25-(0H)zD3 seemed to acccleratc the expression of TNF-a mRNA in LPSstimulated cells (Fig 1B) . In both the abscncc and presence of 1,25-(oH)$3 pretrcatmcnt, the transcript decreased to low levels after about 5 hours in the continued presence of LPS. From these results we chose 2.5 hours of LPS stimulation as the time point for comparison in subsequent cxperimcnts. The incrcasc in TNF-a mRNA levels under the influence of 1,25-(OH)2D3 required that the cells be preexposed to 1,25-(OH)2D3 for more than 6 hours before activation with LPS (Fig 2) ; including the period of incubation with LPS before harvest and extraction (2.5 hours), more than 8.5 hours of hormone exposure was required to observe this stimulatory effect. The increase in TNF-a mRNA levels was most apparent after a 12-hour preincubation period with 1,25-(OH)& and persisted for at least 48 hours. Maximal stimulation of TNF-a levels in LPS-treated For Fig 2) .
Because 1 ,25-(OH)2D3 pretreatment markedly increased the TNF-a mRNA level elicited by a supramaximal concentration of LPS (25 p.g/mL), we tested the response to various concentrations of LPS in cells with or without pretreatment with 10 nmol/L 1,25-(OH)2D3 (Fig 3) . The concentration of LPS required to induce the half-maximal increase in TNF-a mRNA levels in hormone-treated cells ( < 1 ng/mL) was two orders of magnitude lower than that required in cells not exposed to 1,25-(0H)zD3. The ability of 1,25-(OH)2D3 to enhance LPS responsiveness was observed at LPS concentrations as low as 0.1 ng/mL (data not shown).
The ability of 1,25-(OH)2D3 to potentiate stimulated TNF-a gene expression was also observed at the level of cell-associated protein. Fig 4 shows the effect of preexposure of U937 cells to 10 nmol/L 1,25-(OH)2D3 for 24 hours on the accumulation of TNF-a protein in cell sonicates after 2.5 hours of LPS treatment. There was a modest LPS dose-dependent increase in TNF-a protein concentration in the absence of 1,25-(OH)2D3 exposure. At the maximally effective concentration of LPS in these experiments (IO ng/mL) and incubation period with LPS (2.5 hours), TNF-a protein accumulation was magnified ninefold by preincubation with the hormone.
The fact that the sensitivity and overall magnitude of the U937 cell TNF-a response was increased by preexposure to the vitamin D hormone as well as the requirement for more than 8 hours of 1,25-(OH)zD3 preexposure to elicit this increase led us to question whether 1,25-(OH)2D3 altered expression of a protein(s) in the cellular signal transduction pathway responsible for LPS responsiveness. The CD14 molecule has recently been shown to function as a highaffinity, cell surface receptor molecule for LPS.I7 As shown in Fig 5, exposure of U937 cells to 10 nmol/L 1,25-(OH)zD3 for 24 hours resulted in marked induction of the CD14 mRNA. CD14 mRNA levels in untreated U937 cells were undetectable by Northern blot analysis. CD14 mRNA levels remained high through 48 hours of hormone exposure but were diminished by 72 hours. 
DISCUSSION
We recently reported that among the generally available human myclomonocytic cell lines, the U937 cell line was well suited to study the potential immunomodulatory influence of 1,25-(OH)2D3 on human cells of the monocyte/ macrophage lineage.x The U937 cell line constitutively expressed the VDR, making it a receptive target for the hormone. Interaction of 1,25-(OH)2D3 with the VDR in LPS-stimulated U937 cells resulted in a marked increase in the expression of an important monokine gene, IL-lp. This increase in U937 cell IL-Ip gene expression was shown at both thc mRNA and protein level. In this report we have shown that expression of the TNF-a gene in U937 cells is similarly affected by 1,25-(OH)zD3. TNF-a mRNA levels were usually not detectable in the basal state and were induced by activation of the cells with LPS. Preincubation of U937 cells with a VDR-saturating concentration of 1,25-(0H)zD3 before LPS exposure enhanced the magnitude of the LPS-induced increase in TNF-a gene expression (Fig 3A) , accelerated the time course of TNF-a gene expression (Fig lB) , and led to a remarkable increase in sensitivity to the stimulatory influence of LPS on TNF-a gene expression (Fig 3B) . As was the case with the IL-1p gene: increased U937 cell TNF-a expression was steroid specific ( Fig 1A) ; a glucocorticoid receptor-saturating concentration of dexamethasone decreased, not increased, mRNA levels for TNF-a.
The VDR-l,25-(0H)zD3 complex could act by binding to a vitamin D-specific response element in the TNF-a gene, as has been observed in the osteocalcin genet8J9 in which binding leads to accelerated transcription. Several observations suggest that this does not occur in our system and that the effect of 1,25-(OH)2D3 is indirect. The first is the relatively long 1,25-(OH)zD3 preexposure time, greater than 8.5 hours, required to elicit an increase in U937 cell TNF-a mRNA levels after LPS. It might be anticipated that a direct transcriptional effect of the hormone would occur rapidly as has been observed with other genes that are regulated in cis by the VDR-1,25-(OH)2D3 transactivating complexIRJy and as occurs in the suppression observed with dexamethasone ( Fig 1A) . Second, the ability of 1,25-(OH)?D3 to modulate U937 cell-stimulated bioresponsive- macrophages. In an accompanying report" the same investigators discovered the high-affinity LBP-LPS binding event occurred through interaction with the monocytic differentiation antigen, CD14. They showed that LPS concentrations of 1 ng/mL or less are complexed to LBP and bound by the cell surface CD14 glycoprotein, resulting in an LPS dosedependent increase in human peripheral blood mononuclear cell TNF-a production. We postulated that the enhanced sensitivity of U937 cell IL-1p and TNF-a gene expression in response to LPS after a relatively prolonged period of preincubation with 1,25-(OH)zD3 might have resulted from enhanced expression of CD14.
To examine this hypothesis, we assessed steady-state CD14 mRNA levels in U937 cells before and after exposure to 1,25-(OH)zD3 (Fig 5) . Before hormone exposure no CD14 mRNA was detected. After 24 hours of incubation of U937 cells with the hormone there was induction of the CD14 transcript. Considering that the U937 cell line is relatively undifferentiated when compared with circulating monocytesz1 and that 1,25-(OH)2D3 is known to induce maturation of the U937 cell along the monocyte/macrophage lineage,zz it is possible that the expression of CD14 mRNA in U937 cells after incubation with 1,25-(OH)zD3 is part of the differentiation cascade initiated by the hormone. However, the acquisition of the more differentiated phenotype in U937 cells is reported to require at least 3 days of incubation with 1 , 2 5 -( 0 H )~D~~~ long after the apparent 24-hour peak in U937 cell CD14 mRNA levels observed in our experiments. Preliminary work from our laboratory at Cedars-Sinai Medical Centerz4 indicates that the CD14 glycoprotein content of the U937 cell membrane is already increased within 6 to 8 hours after incubation with 1,25-
The induction of CD14 observed in these studies could account for the enhanced sensitivity of U937 cells to LPS after treatment with 1,25-(OH)zD3 as well as the 1,25-
For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From (OH)zD3-mediated acceleration of the time course of TNF-a synthesisZn observed in our studies. The induction of CD14 mRNA and surface protein expression clearly requires several hours, consistent with the observed delay in 1,25-(OH)2D3 potentiation of LPS-induced expression of TNF-a and IL-1P.R However, 1,25-(OH)2D3 may affect TNF-a synthesis through more than one mechanism. We observed at least a twofold increase in TNF-a mRNA levels at LPS concentrations > 100 ng/mL (Fig 3) . These concentrations of LPS stimulate TNF-a expression through a mechanism independent of CD14, because it occurs in the absence of either LBP or CD14.I7 The hormone (1,25-(OH)ZD~) may also augment LPS-stimulated TNF-a synthesis through an LPS-linked signal transduction pathway that is independent of the CD14 molecule. 25 In conclusion, our current studies have shown that 1,25-(OH)zD3 strongly potentiates expression of the TNF-a gene in LPS-activated U937 cells, but does not stimulate TNF-a levels in unactivated cells. In addition to enhancing the magnitude of LPS-stimulated TNF-a mRNA expression and protein production, 1,25-(OH)zD3 also increased the sensitivity of U937 cells to LPS by 100-fold as measured by induced TNF-a gene expression.' These observations in vitro raise the possibility that 1,25-(OH)~D3 produced by activated macrophages at sites of inflammation/infection in vivoz6 may act as an autocrine factor to sensitize the macrophage to activating factors and promote monokine synthesis. In U937 cells, the response to low levels of LPS may result from induction of CD14 expression. It is also possible that 1,25-(OH)2D3 induction of CD14 expression might promote other local important immunoregulatory effects such as enhanced monocyte superoxide product i~n ;~ increased monocyte adherence,28 and inhibition of T-cell pr~liferation.~~
